YOLFTbeta
60

Beijing Winsunny Pharmaceutical CO.LTD

601089 · SHG · Healthcare / Drug Manufacturers - Specialty & Generic

15.02CNY-0.30 (-1.96%)

Price History

Full chart

Market Stats

Previous Close15.32
Open15.34
Day Range15.00 – 15.34
52-Week Range15.28 – 29.97
Volume1.67M
Market Cap7.91B
P/E (TTM)19.62
Forward P/E0.00
EPS0.84
Dividend Yield3.03%
Beta0.11
50-Day Avg16.67
200-Day Avg20.69

About

Beijing Foyou Pharma CO.,LTD engages in the research and development, production, and sale of pharmaceutical formulation and medical devices China. The company offers chemical drugs; traditional Chinese medicine; raw materials; and medical devices, such as negative pressure drainage device, digital urine collection bags, dynamic urine output monitor, disposable pressure sensor, urodynamic monitoring device, nasal air filter, medical micro-mesh nebulizer, disposable atomizer, disposable oxygen mask, and disposable oxygen tubing. It sells its products through medical institutions and retail outlets. The company's products cover cardiovascular system, chronic kidney disease, dermatology, digestive system, diabetes, neuropsychiatric system, and gynecology areas. Beijing Foyou Pharma CO.,LTD was incorporated in 1999 and is headquartered in Beijing, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. He Huang
  • Employees3.91K
  • HeadquartersNo. 8, Guangyuan East Street, Beijing, China, 101113, China
  • Websitehttps://www.foyou.com.cn

Leadership

  • Mr. He HuangChairman & GM · b. 1968
  • Ms. Xu Yan YangFinancial Manager · b. 1980
  • Mr. Yong LiDeputy General Manager · b. 1980
  • Mr. Yuxian GengDeputy General Manager · b. 1974
  • Yan LiAccounting Supervisor

Financials

Income Statement

Currency: CNY2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue2.54B2.84B3.24B3.34B3.45B3.50B
Growth (%)-+11.93%+14.18%+3.07%+3.17%+1.71%
Cost of Revenue733.20M865.30M1.03B1.11B1.13B1.21B
Gross Profit1.80B1.97B2.21B2.23B2.31B2.30B
Gross Margin71.08%69.51%68.23%66.63%67.09%65.51%
Operating Expense1.48B1.60B1.75B1.72B1.80B1.77B
Operating Income322.04M369.26M458.37M510.07M507.50M523.66M
Operating Margin12.70%13.01%14.15%15.27%14.73%14.94%
EBITDA--573.56M652.26M645.59M653.99M
EBITDA Margin--17.70%19.53%18.74%18.66%
Net Income262.71M314.47M438.90M488.77M488.67M469.36M
Net Income Margin10.36%11.08%13.55%14.64%14.18%13.39%
R&D140.88M179.66M239.74M353.33M417.37M403.42M
R&D as % of Total Revenue5.56%6.33%7.40%10.58%12.11%11.51%
Interest Expense11.10M6.51M4.76M5.34M3.50M1.58M
Interest Expense % of Total Revenue0.44%0.23%0.15%0.16%0.10%0.05%

Balance Sheet

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-1.72B2.15B4.32B4.55B4.82B4.92B
Total Liabilities-709.01M937.86M1.14B1.07B1.26B1.13B
Total Equity-1.01B1.21B3.17B3.47B3.54B3.78B
Cash-270.24M434.69M2.54B2.53B794.07M634.36M

Cash Flow

Currency: CNY2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow386.65M528.02M659.76M555.90M690.75M360.85M
Capital Expenditure168.96M192.97M135.40M366.08M391.52M397.41M
Free Cash Flow217.69M335.05M524.36M189.82M299.23M-36.55M
Dividends Paid119.28M114.21M111.22M194.60M236.59M234.24M
FCF to OCF56.30%63.45%79.48%34.15%43.32%-10.13%
Dividend Paid to FCF54.79%34.09%21.21%102.51%79.07%-640.84%

Earnings

Report DateSep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023
EPS Estimate----
EPS Actual0.260.220.240.28
Surprise----
Timing----

Key Statistics & Ratios

Market Cap7.91B
Enterprise Value5.79B
Trailing P/E19.62
Forward P/E0.00
Price / Sales2.21
Price / Book2.10
EPS0.84
Book Value7.97
Revenue (TTM)3.58B
Gross Profit (TTM)2.22B
EBITDA516.91M
Profit Margin10.83%
Operating Margin8.94%
Return on Equity10.65%
Return on Assets5.07%
Shares Outstanding480.00M
Shares Float116.72M
Beta0.11
Dividend Yield3.03%
Dividend Rate0.50
Payout Ratio59.52%

Dividends

20261×
0.50Jun 2, 2026
20251×
0.50Jun 6, 2025
20241×
0.50Jun 14, 2024
20231×
0.40May 26, 2023